Qian Liu

Title: Innovations by Qian Liu in Diffuse Large B-Cell Lymphoma Classification

Introduction

Qian Liu is an accomplished inventor based in Lynn, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the classification of diffuse large B-cell lymphoma (DLBCL). His innovative work aims to enhance the diagnosis, prognosis, and therapy selection for patients suffering from this type of cancer.

Latest Patents

Qian Liu holds a patent for "Methods for subtyping diffuse large B-cell lymphoma (DLBCL)." This patent describes innovations for classifying subtypes of DLBCL, which can effectively aid in providing meaningful outputs for medical practices and DLBCL patients. The patent also includes details about arrays and kits that can be utilized to measure the expression of DLBCL signature genes. He has 1 patent to his name.

Career Highlights

Qian Liu is currently employed at Htg Molecular Diagnostics, Inc., where he continues to develop and refine diagnostic methods for cancer. His work is pivotal in advancing the understanding and treatment of DLBCL, making a significant impact on patient care.

Collaborations

Qian Liu collaborates with notable colleagues, including Bonnie LaFleur and John W. Luecke. These partnerships enhance the research and development efforts at Htg Molecular Diagnostics, Inc., fostering an environment of innovation and discovery.

Conclusion

Qian Liu's contributions to the classification of diffuse large B-cell lymphoma represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to benefit the medical community and improve patient outcomes.